Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Réduire les Risques de Guerre Nucléaire : Le Rôle des Professionnels de la Santé].
Kamran A, Parveen A, Virginia B, Kirsten BD, Marcel Gm OR, Peng G, Andy H, Ira H, Richard H, Bob M, Arun M, Carlos M, Elena N N, Eric J R, Tilman R, Peush S, James T, Paul Y, Chris Z. Kamran A, et al. Among authors: virginia b. West Afr J Med. 2023 Oct 31;40(10):1011-1012. West Afr J Med. 2023. PMID: 37905894 French. No abstract available.
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
Millar PR, Gordon BA, Luckett PH, Benzinger TLS, Cruchaga C, Fagan AM, Hassenstab JJ, Perrin RJ, Schindler SE, Allegri RF, Day GS, Farlow MR, Mori H, Nübling G; Dominantly Inherited Alzheimer Network; Bateman RJ, Morris JC, Ances BM. Millar PR, et al. Elife. 2023 Jan 6;12:e81869. doi: 10.7554/eLife.81869. Elife. 2023. PMID: 36607335 Free PMC article.
Dupilumab-induced Urticaria.
Mastorino L, Ortoncelli M, Virginia B, Rolla G, Avallone G, Cavaliere G, Riccardo V, Quaglino P, Ribero S. Mastorino L, et al. Among authors: virginia b. Dermatol Ther. 2021 Nov;34(6):e15117. doi: 10.1111/dth.15117. Epub 2021 Sep 6. Dermatol Ther. 2021. PMID: 34459079 No abstract available.
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB; RUBY-1 Investigators. Steg PG, et al. Eur Heart J. 2011 Oct;32(20):2541-54. doi: 10.1093/eurheartj/ehr334. Epub 2011 Aug 30. Eur Heart J. 2011. PMID: 21878434 Free PMC article. Clinical Trial.